HOME >> MEDICINE >> NEWS
There are a few 'safe' days in menstrual cycle

Guidelines for getting pregnant -- or avoiding pregnancy -- usually assume an average woman is fertile between days 10 and 17 of her menstrual cycle. But researchers at the National Institute of Environmental Health Sciences have demonstrated what some accidentally pregnant women may have long suspected: Only about 30 percent of women actually have their fertile window entirely within that timespan.

In fact, the researchers found, there is hardly a day in the menstrual cycle during which some women are not potentially fertile. Women in this study were of prime reproductive age (most between 25 and 35), when the menstrual cycles are most regular. Because teenagers and women approaching menopause have less regular cycles, their windows of fertility might be even more unpredictable.

Describing data from nearly 700 menstrual cycles of 213 healthy North Carolina women, NIEHS' Allen J. Wilcox, M.D., Ph.D., statistician David Dunson, Ph.D., and epidemiologist Donna Day Baird, Ph.D., reported in the British Medical Journal (Vol. 321, pp 1259-1262) that the timing of women's fertile window "can be highly unpredictable, even if their cycles are usually regular."

Dr. Wilcox, a physician and chief of epidemiology at NIEHS, said, "If the average healthy couple wants to get pregnant, they are just as well off to forget 'fertile windows' and simply engage in unprotected intercourse two or three times a week." As for those seeking to use the cycle to avoid pregnancy, the odds are not good. "Our data suggest there are few days of the menstrual cycle during which some women are not potentially capable of becoming pregnant - including even the day on which they may expect their next menses to begin," according to the new scientific report.

With cycle day one being the day of the actual onset of menstrual bleeding, the researchers showed that 2 percent of women were starting their fertile window by day four, 17 percent by day seven. More tha
'"/>

Contact: Bill Grigg
grigg@niehs.nih.gov
301-402-3378
NIH/National Institute of Environmental Health Sciences
16-Nov-2000


Page: 1 2

Related medicine news :

1. Will an apple a day keep the doctor away? There are better food choices, research notes
2. Deaths Related To Intrapartum Asphyxia - Is There A Problem With Prevention?
3. Air pollution, even at safe levels, is bad for the heart
4. Scientific forum addresses menstrual cycle as vital sign
5. Heavy menstrual periods associated with economic loss
6. Causes of menstrual migraine explored
7. Energy balance, not exercise, key to athletic menstrual disturbance
8. Investigational oral contraceptive reduces premenstrual and menstrual symptoms
9. Tracing the life cycle of a manmade disease
10. Urban hospitals bear the brunt of motorcycle injuries
11. Weekly cycles of once-daily anti-HIV drugs could reduce cost of HIV treatment

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: There are few safe days menstrual cycle

(Date:3/30/2015)... March 30, 2015 Mid-America ATTC ... library of medications used in behavioral health and ... iPad and Android—is a convenient, electronic version of ... 1999. The useful resource provides up-to-date information on ... and frequency, side effects, emergency conditions, cautions, considerations ...
(Date:3/30/2015)... Linda, CA (PRWEB) March 30, 2015 ... challenging due to the use of cellular models that ... not the entirety of the disease. , A ... human cells to precise specifications has created ... to develop environmentally and genetically driven in vitro models ...
(Date:3/29/2015)... Calif. (PRWEB) March 30, 2015 Over ... menopause-related symptoms tied to undiagnosed autoimmune, thyroid, or hormone ... thyroid disorders, has personally treated hundreds of patients dealing ... are unaware of the treatment options for their ailments. ... offers solutions to women living with fatigue, brain fog, ...
(Date:3/29/2015)... Telerad RxDx Multispecialty Healthcare Center, ... Accreditation on 11th January 2015. The accreditation from ... Providers) comes as a true recognition of the ... RxDx., With Telerad RxDx being the first healthcare ... marks a major achievement and a significant step ...
(Date:3/29/2015)... March 29, 2015 At this ... platform provides basic health information around medical conditions ... discuss these challenges as well as helping them ... addresses six medical conditions using evidenced based information ... engage in conversations around them., ...
Breaking Medicine News(10 mins):Health News:Popular Publication on Behavioral Health Medications Now An App 2Health News:Cellular Dynamics’ Webinar Spotlights Diabetic Cardiomyopathy-in-a-dish Model that May Elucidate Mechanisms for Repair and Regeneration of Heart Muscle Cells 2Health News:Cellular Dynamics’ Webinar Spotlights Diabetic Cardiomyopathy-in-a-dish Model that May Elucidate Mechanisms for Repair and Regeneration of Heart Muscle Cells 3Health News:Cellular Dynamics’ Webinar Spotlights Diabetic Cardiomyopathy-in-a-dish Model that May Elucidate Mechanisms for Repair and Regeneration of Heart Muscle Cells 4Health News:How to Turn Mid-life into the Good Life 2Health News:NABH Accreditation for Telerad RxDx – Whitefield. 2Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 2Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 3
(Date:3/30/2015)... , March 30, 2015  BioDelivery Sciences International, ... primary efficacy endpoint in the Phase 3 clinical ... for the treatment of painful diabetic neuropathy did ... showed statistically significant improvement over placebo.  In addition, ... observed.  The results of this trial provide data ...
(Date:3/29/2015)... 2015  Three-month paliperidone palmitate, an investigational atypical ... placebo in patients with schizophrenia, according to a ... in the Journal of the American ... Results of the study served as the basis ... for three-month paliperidone palmitate injection to treat schizophrenia ...
(Date:3/27/2015)... - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: ... issuance of an aggregate of 30,000 stock options to ... of 120,500 stock options to employees and consultants of ... years and will be exercisable for a period of ... stock option. About Covalon Covalon Technologies ...
Breaking Medicine Technology:BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 2BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 3BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 4BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 2New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 4New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 6New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 7New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 8New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 9New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 10New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 11New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 12Covalon Announces Issuance of Stock Options 2
Cached News: